Silbermann Susan's most recent trade in LianBio - ADR was a trade of 36,300 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LianBio - ADR | Silbermann Susan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 36,300 | 0 | - | - | Stock Option (Right to Buy) | |
| LianBio - ADR | Silbermann Susan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.52 per share. | 15 Feb 2024 | 36,300 | 36,300 | - | 2.5 | 91,476 | Ordinary Shares |
| LianBio - ADR | Silbermann Susan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 15 Feb 2024 | 19,218 | 17,082 | - | 4.8 | 91,478 | Ordinary Shares |
| HilleVax Inc | Susan Silbermann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 25,000 | 25,000 | - | - | Stock Option |